Khudoley V, Malaveille C, Bartsch H
Cancer Res. 1981 Aug;41(8):3205-10.
N-Nitrodimethylamine, N-nitrodiethylamine, N-nitromorpholine and their N-nitroso analogs, N-nitrosodimethylamine, N-nitrosodiethylamine, and N-nitrosomorpholine, were tested in Salmonella typhimurium strains TA100 and TA1530. The mutagenicity of all compounds, except N-nitrodiethylamine, was demonstrated in liquid incubation assays in at least one of the tester strains; it required the presence of a postmitochondrial supernatant from the liver of Aroclor-treated rats, reduced nicotinamide adenine dinucleotide phosphate-generating system, and oxygen. When compared on a molar basis with their N-nitroso analogs, N-nitromorpholine was about 10 times less mutagenic and N-nitrodimethylamine about 70 times less mutagenic. Addition of disulfiram to the assays at a final concentration of 0.1 mM efficiently inhibited mutagenesis by all nitro and nitroso compounds; ascorbic acid at a 7.4 mM concentration produced less inhibition. Mutagenic activity of the three nitramines was also determined in the host-mediated assay in rats. After p.o. administration of each of the N-nitramines, cells of S. typhimurium strains TA1530 and TA100 that had been injected i.p. were isolated from the peritoneal liquid after 1, 3, and 6 hr. All three nitramines were found to be mutagenic for strain TA1530 but not for TA100. Mutation frequencies (number of histidine revertants per 10(6) surviving cells) were in the descending order N-nitromorpholine greater than N-nitrodiemethylamine greater than N-nitrodiethylamine. After a p.o. dose of N-nitrodiethylamine to rats, bacteria were also isolated from liver, lungs, and kidneys. Mutation frequency was highest in bacteria recovered from the liver but was not increased in those obtained from lungs and kidneys. The data suggest that carcinogenic nitramines exert their mutagenic effects through the formation of alkylating intermediates.
对N-硝基二甲胺、N-硝基二乙胺、N-硝基吗啉及其N-亚硝基类似物N-亚硝基二甲胺、N-亚硝基二乙胺和N-亚硝基吗啉,在鼠伤寒沙门氏菌TA100和TA1530菌株中进行了测试。除N-硝基二乙胺外,所有化合物的诱变性在液体培养试验中至少在一种测试菌株中得到证实;这需要来自经多氯联苯处理的大鼠肝脏的线粒体后上清液、还原型烟酰胺腺嘌呤二核苷酸磷酸生成系统和氧气的存在。当按摩尔基础与其N-亚硝基类似物比较时,N-硝基吗啉的诱变性约低10倍,N-硝基二甲胺约低70倍。在试验中加入终浓度为0.1 mM的双硫仑能有效抑制所有硝基和亚硝基化合物的诱变作用;浓度为7.4 mM的抗坏血酸产生的抑制作用较小。还在大鼠的宿主介导试验中测定了三种硝胺的诱变活性。经口服给予每种N-硝胺后,在1、3和6小时后从腹腔液中分离出经腹腔注射的鼠伤寒沙门氏菌TA1530和TA100菌株的细胞。发现所有三种硝胺对TA1530菌株有诱变性,但对TA100菌株无诱变性。突变频率(每10(6)个存活细胞中组氨酸回复突变体的数量)按降序排列为N-硝基吗啉>N-硝基二甲基胺>N-硝基二乙胺。给大鼠口服N-硝基二乙胺剂量后,还从肝脏、肺和肾脏中分离出细菌。从肝脏中回收的细菌中突变频率最高,但从肺和肾脏中获得的细菌中突变频率未增加。数据表明致癌硝胺通过形成烷基化中间体发挥其诱变作用。